[The surgical treatment of fibrous-cavernous pulmonary tuberculosis in patients with diabetes mellitus].
The results of treatment of fibrocavernous tuberculosis in 75 patients with diabetes mellitus were analyzed. In 21 (28%) patients postoperative complications occurred. After the operation 4 (5.33%) patients died. In 94.67% of patients clinical efficacy was achieved. While 1 to 15-year period of observation a full clinical effect was noted in 83.8% of 37 examined patients and the tuberculosis reactivation was revealed in 10.8%.
Voloshyn
Ia M
IaM
D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy; D011300:Preoperative Care; D013997:Time Factors; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*
D000995:Antitubercular Agents